S Achilefu

Summary

Publications

  1. ncbi request reprint Novel receptor-targeted fluorescent contrast agents for in vivo tumor imaging
    S Achilefu
    Discovery Research, Mallinckrodt Inc, St Louis, Missouri 63042, USA
    Invest Radiol 35:479-85. 2000
  2. ncbi request reprint Novel fluorescent contrast agents for optical imaging of in vivo tumors based on a receptor-targeted dye-peptide conjugate platform
    J E Bugaj
    Mallinckrodt Inc, P.O. Box 5840, St. Louis, Missouri 63134-0840, USA
    J Biomed Opt 6:122-33. 2001
  3. pmc Preclinical evaluation of Mab CC188 for ovarian cancer imaging
    M Xu
    Department of Radiology, Washington University School of Medicine, St Louis, MO, USA
    Int J Cancer 131:1351-9. 2012
  4. pmc Fluorescence lifetime imaging microscopy using near-infrared contrast agents
    R Nothdurft
    Washington University, School of Medicine, Department of Radiology, Scott Avenue, St Louis, Missouri 63110, USA
    J Microsc 247:202-7. 2012

Collaborators

  • J E Bugaj
  • R Nothdurft
  • M Xu
  • S Bloch
  • D G Mutch
  • W J Akers
  • B Wang
  • G Sudlow
  • D Cao
  • J F Dipersio
  • J Culver
  • M P Rettig
  • P Sarder

Detail Information

Publications4

  1. ncbi request reprint Novel receptor-targeted fluorescent contrast agents for in vivo tumor imaging
    S Achilefu
    Discovery Research, Mallinckrodt Inc, St Louis, Missouri 63042, USA
    Invest Radiol 35:479-85. 2000
    ..To evaluate the efficacy of a novel tumor receptor-specific small-peptide-near-infrared dye conjugate for tumor detection by optical imaging...
  2. ncbi request reprint Novel fluorescent contrast agents for optical imaging of in vivo tumors based on a receptor-targeted dye-peptide conjugate platform
    J E Bugaj
    Mallinckrodt Inc, P.O. Box 5840, St. Louis, Missouri 63134-0840, USA
    J Biomed Opt 6:122-33. 2001
    ..The resulting optical images clearly show that successful specific tumor targeting was achieved. Thus, we have demonstrated that small peptide-dye conjugates are effective as contrast agents for optical imaging of tumors...
  3. pmc Preclinical evaluation of Mab CC188 for ovarian cancer imaging
    M Xu
    Department of Radiology, Washington University School of Medicine, St Louis, MO, USA
    Int J Cancer 131:1351-9. 2012
    ..The tumor uptake was still evident at 120-hr postinjection. Our work suggests that Mab CC188-based imaging and therapeutic reagents are capable of detecting early stage ovarian tumors and effectively treating the tumor...
  4. pmc Fluorescence lifetime imaging microscopy using near-infrared contrast agents
    R Nothdurft
    Washington University, School of Medicine, Department of Radiology, Scott Avenue, St Louis, Missouri 63110, USA
    J Microsc 247:202-7. 2012
    ....